Predictions
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.94
02.10.23
02.10.23
-
02.10.24
02.10.24
-13.79%
15.10.23
15.10.23
Could be very worthwhile Investment >20% year
Sportsmans Wareh.ho.
Start price
Target price
Perf. (%)
€4.28
01.10.23
01.10.23
€4.50
30.09.25
30.09.25
11.68%
16.10.23
16.10.23
Could be very worthwhile Investment >20% year
Aldeyra Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.42
01.10.23
01.10.23
€10.00
30.11.25
30.11.25
-73.55%
16.10.23
16.10.23
Could be very worthwhile Investment >20% year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.41
01.10.23
01.10.23
€3.00
31.01.26
31.01.26
-74.00%
18.06.24
18.06.24
Could be very worthwhile Investment >20% year
Immunic Inc.
Start price
Target price
Perf. (%)
€1.37
01.10.23
01.10.23
€3.00
28.02.26
28.02.26
-13.40%
18.02.24
18.02.24
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€47.80
01.10.23
01.10.23
€65.00
30.06.26
30.06.26
-71.13%
13.10.23
13.10.23
Could be very worthwhile Investment >20% year
Hersha Hospitality Trust
Start price
Target price
Perf. (%)
€9.25
01.10.23
01.10.23
-
01.10.24
01.10.24
-3.24%
27.11.23
27.11.23
Atlantic Tele-Network Inc.
Start price
Target price
Perf. (%)
€29.80
01.10.23
01.10.23
-
01.10.24
01.10.24
-28.74%
19.07.24
19.07.24
Baozun Inc ADR
Start price
Target price
Perf. (%)
€3.02
01.10.23
01.10.23
€2.50
01.10.24
01.10.24
-22.52%
18.07.24
18.07.24
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.84
01.10.23
01.10.23
€1.20
01.10.24
01.10.24
7.61%
19.07.24
19.07.24
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Tecnoglass Inc
Start price
Target price
Perf. (%)
€31.40
01.10.23
01.10.23
€54.00
01.10.24
01.10.24
51.66%
19.07.24
19.07.24
positive Cash Flow expected
Higher EBIT margin than peer group
Bad culture
Very low/no dividend yield expected
Myers Industries Inc.
Start price
Target price
Perf. (%)
€16.90
30.09.23
30.09.23
-
30.09.24
30.09.24
-19.09%
19.07.24
19.07.24
US Physical Therapy Inc.
Start price
Target price
Perf. (%)
€86.50
30.09.23
30.09.23
-
30.09.24
30.09.24
1.39%
19.07.24
19.07.24
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.70
30.09.23
30.09.23
-
30.09.24
30.09.24
27.10%
19.07.24
19.07.24
Powell Industries Inc.
Start price
Target price
Perf. (%)
€78.50
30.09.23
30.09.23
-
30.09.24
30.09.24
52.65%
19.07.24
19.07.24
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€0.14
30.09.23
30.09.23
-
30.09.24
30.09.24
-
08.09.23
08.09.23
Mithra Pharmaceuticals S.A.
Start price
Target price
Perf. (%)
€1.40
30.09.23
30.09.23
€1.00
30.09.24
30.09.24
-21.00%
14.10.23
14.10.23
Probably not worthwhile Investment
Bad rating
Little Investments for future growth
Risky balance sheet
Capricor Therapeutics Inc
Start price
Target price
Perf. (%)
€3.32
30.09.23
30.09.23
€1.00
30.09.24
30.09.24
-17.17%
14.10.23
14.10.23
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
